ReviewFrontiers in oncology2022

Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A review.

Liwei Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.